Adam Gefvert
Adam Gefvert
Send Message
Adam Gefvert
Stop FollowingAdam Gefvert
View as an RSS Feed
COMMENTS STATS
1,203 Comments
521 Likes

Upcoming Lawsuits Will Likely Leave Affymax Shareholders With Nothing [View article]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
Several Catalysts Are Near For Peregrine Pharmaceuticals [View article]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
Here's what he said before that quote: "Looking at our manufacturing capacity roadmap, we see limited production in the second quarter and ramp up to volume production in the third quarter."
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
"We are on target to hit 45,000 to 60,000 units or square feet per month by the end of April; 200,000 by the end of June, 700,000 by the end of September and then achieving 1.3 million units monthly by January of 2014."
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
They said they were going to do 60,000. Can anyone confirm this? If they are missing numbers already, this could be a great shorting opportunity.
I have no position at the moment.
Ampio Pharma Initiates Phase III, Investors Extend Momentum [View article]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
UniPixel: Intel Shows Its Touch Sensor Hand [View instapost]
Several Catalysts Are Near For Peregrine Pharmaceuticals [View article]
Several Catalysts Are Near For Peregrine Pharmaceuticals [View article]